Velano Vascular has developed a simple, game-changing innovation that will improve the way medicine has been practiced for decades.
Sentiment: POSITIVE
No matter how counter-intuitive it may seem, basic research has proven over and over to be the lifeline of practical advances in medicine.
Paradoxically, no such embargo exists for the drugs and therapies that have revolutionized the treatment of serious diseases although many of them were created with the same technologies.
It is very clear that the present system of innovation for medicines is very inefficient and really somewhat corrupt. It benefits shareholders over patients; it produces for the rich markets and not for the poor and does not produce for minority diseases.
So someday in the near future hopefully rather than having a foot or a leg amputated we'll just give you an injection of the cells and restore the blood flow. We've also created entire tubes of red blood cells from scratch in the laboratory. So there are a lot of exciting things in the pipeline.
Modern medical advances have helped millions of people live longer, healthier lives. We owe these improvements to decades of investment in medical research.
No one would say, 'Hey, I think this medicine works, go ahead and use it.' We have testing, we go to the lab, we try it again, we have refinement. But you know what we do on the last mile? 'Oh, this is a good idea. People will like this. Let's put it out there.'
In general, drug companies are reasonably good at developing new treatments, and there's also a lot of good in the industry.
We are looking at gene therapies to Reverse Atherosclerosis, Regenerate muscles and tissue, Improve cell signaling, Clear misfolded Proteins, Rejuvenate the immune System, Clear Senescent Cells, and Treat Monogenic Diseases.
New drugs and surgical techniques offer promise in the fight against cancer, Alzheimer's, tuberculosis, AIDS, and a host of other life-threatening diseases. Animal research has been, and continues to be, fundamental to advancements in medicine.
What we discovered, counter-intuitively, is that when you start killing a cancer cell, one of the things it does in order to survive is to spread even further. It causes itself to form new blood vessels. We've termed this 'reactionary angiogenesis.'
No opposing quotes found.